{
  "id" : "pretext_clinical_staging_39169",
  "algorithm" : "pediatric",
  "version" : "1.3",
  "name" : "Pretext Clinical Staging",
  "title" : "Pretext Clinical Staging",
  "description" : "PRETEXT stands for PRE-Treatment Extent of tumor. This field describes the extent of involvement within the four lobes of the liver at time of a pediatric liver tumor diagnosis. It is based off clinical imaging and was originally designed to standardize imaging evaluation and risk stratification of hepatoblastoma before neoadjuvant chemotherapy or tumor resection.",
  "notes" : "**Note 1:** **Effective years**\n* This SSDI is effective for diagnosis years 2024+\n* For cases diagnosed 2018-2023, this SSDI must be blank\n\n**Note 2:** **Criteria for coding**\n* This SSDI is based on imaging findings only. **Do not** code any findings from surgical resection in this data item. Evaluation must also be done prior to any neoadjuvant therapy\n\n**Note 3:** **Pretext Staging-Segments of the liver**\n* Caudate liver: Segment I \n**Note:** Involvement of the caudate liver is at minimum Stage 2\n* Left lateral section: Segments II & III\n* Left medial section: Segments IVA & IVB\n* Right anterior section: Segments V & VIII\n* Right posterior section: Segments VI & VII",
  "last_modified" : "2024-04-10T16:52:03.858Z",
  "definition" : [ {
    "key" : "pretext_clinical_staging",
    "name" : "Code",
    "type" : "INPUT"
  }, {
    "key" : "description",
    "name" : "Description",
    "type" : "DESCRIPTION"
  } ],
  "rows" : [ [ "1", "One section involved; three adjoining sections are tumor free\n\nStage I, Pretext 1" ], [ "2", "One or two sections involved; two adjoining sections are tumor free\n\nStage 2, Pretext 2" ], [ "3", "Two or three sections involved; one adjoining section is tumor free\n\nStage 3, Pretext 3" ], [ "4", "Four sections involved\n\nStage 4, Pretext 4" ], [ "8", "Not applicable: Information not collected for this case\n(If this information is required by your standard setter, use of code 8 may result in an edit error.)" ], [ "9", "Not documented in medical record\nCannot be determined by pathologist\nPRETEXT not assessed or unknown if assessed" ], [ "", "N/A - Diagnosis year is prior to 2024" ] ],
  "rationale" : "After initially being created by the International Childhood Liver Tumours Strategy Group (SIOPEL) in 1990, PRETEXT was introduced for use within the United States in 2014 by the Childrenâ€™s Oncology Group (COG) once radiographic imaging became more sophisticated and exploratory surgery at diagnosis was no longer advisable. It is used as a central component of risk stratification schemes that define treatment of hepatoblastoma."
}